Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional paid in capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Balances at Dec. 31, 2022	$ 516,195	$ 4	$ 973,145	$ (15,401)	$ (441,553)
Balances (Shares) at Dec. 31, 2022		43,299
Vesting of restricted stock units, net of tax	(419)		(419)
Vesting of restricted stock units, net of tax, shares		127
Exercise of stock options, net of tax	1,220		1,220
Exercise of stock options, net of tax, shares		165
Issuance of common stock under employee stock purchase plan	583		583
Issuance of common stock under employee stock purchase plan, shares		30
Stock-based compensation expense	21,710		21,710
Unrealized gain on available-for-sale securities, net	5,303			5,303
Net loss	(138,737)				(138,737)
Balances at Jun. 30, 2023	405,855	$ 4	996,239	(10,098)	(580,290)
Balances (Shares) at Jun. 30, 2023		43,621
Balances at Mar. 31, 2023	465,139	$ 4	984,986	(11,622)	(508,229)
Balances (Shares) at Mar. 31, 2023		43,465
Vesting of restricted stock units, net of tax, shares		28
Exercise of stock options, net of tax	749		749
Exercise of stock options, net of tax, shares		128
Stock-based compensation expense	10,504		10,504
Unrealized gain on available-for-sale securities, net	1,524			1,524
Net loss	(72,061)				(72,061)
Balances at Jun. 30, 2023	405,855	$ 4	996,239	(10,098)	(580,290)
Balances (Shares) at Jun. 30, 2023		43,621
Balances at Dec. 31, 2023	311,742	$ 4	1,021,214	(4,429)	(705,047)
Balances (Shares) at Dec. 31, 2023		44,046
Vesting of restricted stock units, net of tax	(910)		(910)
Vesting of restricted stock units, net of tax, shares		309
Exercise of stock options, net of tax	1,076		1,076
Exercise of stock options, net of tax, shares		173
Exercise of pre-funded warrants		197
Issuance of common stock under employee stock purchase plan	411		411
Issuance of common stock under employee stock purchase plan, shares		27
Issuance of common stock and pre-funded warrants upon public offering	131,067	$ 1	131,066
Issuance of common stock and pre-funded warrants upon public offering, shares		4,565
Stock-based compensation expense	19,037		19,037
Unrealized gain on available-for-sale securities, net	2,163			2,163
Net loss	(116,319)				(116,319)
Balances at Jun. 30, 2024	348,267	$ 5	1,171,894	(2,266)	(821,366)
Balances (Shares) at Jun. 30, 2024		49,317
Balances at Mar. 31, 2024	390,666	$ 5	1,162,267	(3,229)	(768,377)
Balances (Shares) at Mar. 31, 2024		49,043
Vesting of restricted stock units, net of tax, shares		39
Exercise of stock options, net of tax	192		192
Exercise of stock options, net of tax, shares		38
Exercise of pre-funded warrants		197
Stock-based compensation expense	9,435		9,435
Unrealized gain on available-for-sale securities, net	963			963
Net loss	(52,989)				(52,989)
Balances at Jun. 30, 2024	$ 348,267	$ 5	$ 1,171,894	$ (2,266)	$ (821,366)
Balances (Shares) at Jun. 30, 2024		49,317